HNRNPH1 acts as a regulator of cell proliferation and progression of disease in chronic myeloid leukemia [36,37], HOXA9 acts as an anti-apoptotic gene promoting MYC-mediated leukemogenesis by the ability to maintain gene expression for multiple anti-apoptotic pathways [38,39], and HIST1H2BM is known to be expressed in breast cancer [40,41]. Here, HNRNPH1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.